What this world covers
Cognition means: attention, working memory, executive function, processing speed, learning and consolidation, mood stability under load. This world bundles the substances that show reproducible effects in at least one of these dimensions — from the classical nootropic Bacopa Monnieri through choline compounds to adaptogens like Rhodiola and stimulating substances like modafinil.
Important: cognitive performance is methodologically hard to measure. Reaction time, n-back tests, Stroop tests, executive function in standardized batteries — none of these measures captures "intelligence" or "clarity" directly. Studies work with surrogates whose ecological validity (transferability to daily life) is often limited. That makes the evidence discussion in this world especially sensitive.
Why the order matters
Nobody needs a 12-substance nootropic stack that delivers 3 % more attention while sleeping 6 h, drinking 4 espressos in the afternoon and never strength training. The most common trap in this world: substances are used to compensate symptoms whose cause is lifestyle-based.
Pragmatically: 1) correct sleep architecture (7–9 h, ±30 min wake time), 2) dose caffeine strategically (200–400 mg/day, nothing after 2 PM), 3) establish strength training + cardio, 4) clarify micronutrient base (World 01, especially vitamin D, B12, omega-3, iron). Only then work with targeted nootropics — and even then usually with 1–2 substances, not ten.
The most important levers
Bacopa Monnieri
The nootropic with the most robust cognitive evidence: reproducible memory improvement, learning rate and delayed recall in at least six RCTs in healthy adults (Pase meta-analysis 2012).
Protocol:
- 300 mg standardized extract (50 % bacosides)
- 1×/day with a meal (better absorbed with fat)
- Minimum 8–12 weeks, effect builds slowly
- Effect size: g ≈ 0.3–0.5 (moderate but consistent)
Trade-offs: mild GI complaints often in the first days, then resolved. Sedating component in some — take in evening.
Choline compounds (Alpha-GPC, citicoline)
Precursors to acetylcholine, the most important neurotransmitter for attention and working memory. Effects are status-dependent: pronounced in choline deficiency, marginal with sufficient diet (eggs, organ meats).
Dosing:
- Alpha-GPC: 300–600 mg/day — slightly stronger in sports performance
- Citicoline: 250–500 mg/day — slightly stronger in attention and aging
When combined with racetams (piracetam family) a classic stack — racetams themselves with thin modern evidence base.
Adaptogens (Rhodiola, ashwagandha)
Don't work acutely like caffeine but as chronic stress buffers.
Rhodiola Rosea (300–600 mg, 3 % rosavins):
- Stress-related fatigue −20–25 % in RCTs
- Mental performance under load improved
- Acute component felt after 60–90 min
Ashwagandha (300–600 mg KSM-66):
- Cortisol −20–30 %, sleep-promoting, anxiolytic
- Less acute cognitive effect, more mood stability
- Caution with Hashimoto — can upregulate thyroid hormones
Modafinil
Prescription-only, robust evidence for wakefulness and attention. Off-label use widespread but with risks: rash (rarely Stevens-Johnson), headache, sleep disorders, tolerance development.
Stance: not a self-tracking experiment but a medical substance with indication. Self-medication from the internet is risky — source quality is not assured.
How we rate evidence
Cognitive outcomes are methodologically delicate — placebo effects high, individual variability large, measurement tools often not life-relevant. We weight:
- Meta-analyses with standardized cognitive test batteries
- RCTs with ≥ 50 participants and ≥ 8 weeks duration
- Acute studies with reaction time and n-back tests (short-term, less relevant for chronic use)
- Subjective self-reports and questionnaires (flagged, interpreted with caution)
- Animal and cell studies (only hypothesis-generating)
Important: we distinguish between healthy young adults (higher cognitive baseline, less to gain) and older people with deficits (more room for improvement, different effect sizes). Effects often don't transfer.
Most common effects and interactions
Nootropics interact with neurotransmitter systems that modulate each other:
- Caffeine + L-theanine (100 mg + 200 mg) — the best-supported acute combo for attention without jitter.
- Bacopa + choline source — synergistic via cholinergic signaling; many users report clearer effects.
- Modafinil + SSRIs — possible, but check cytochrome interactions.
- Methylene blue + SSRIs / SNRIs — contraindicated (serotonin syndrome).
- High tyrosine doses + MAO inhibitors — contraindicated.
- Adaptogens + thyroid hormones — effects can add up, watch values.
What does NOT belong in this world
- Choline as a micronutrient (status correction) → World 01 (Foundation)
- Meditation, mindfulness → World 09 (Mental)
- Sleep substances like glycine, apigenin → World 08 (Sleep)
- Hormonal modulators like testosterone → World 03 (Hormones)
- GH peptides (with cognitive claims) → World 04 (Peptides)
Omega-3 (EPA/DHA) is cognitively effective but belongs primarily in World 01 — status correction is the foundation cognition benefits from.
How Biohacking AI operationalizes this
This world requires more skepticism and less stack-building than any other:
- The Stack-Builder flags redundancies — anyone taking Bacopa, Lion's Mane and citicoline simultaneously often has three substances with overlapping effects. It prioritizes: what has the best evidence for your goal.
- The Studies database filters per substance the human outcome studies first — animal and mechanism studies are clearly separated.
- The Forum collects self-test protocols with before/after measurements — no affiliate marketing, no miracle stacks, clear notation of subjective effects.
- The Coach is especially conservative here: sleep, caffeine strategy, basics, then Bacopa, then targeted adaptogens — everything else with critical burden of proof.
The goal is not "more substances for more clarity." The goal is: find the two or three levers that really work in your context — and skip everything else.